clockwire Search
LIVE
US flight chaos caused by repair of old copper wiring: Trump admin The growing threat of fake photocards It’s going down to the wire: Parties meet across earlier red lines in coalition confusion ASEAN Summit opens in Manila with focus on regional unity amid global changes Delhi AQI at 511: Breathing capital's toxic air equals smoking 375 cigarettes a month; chances of asthma, heart issues Chelle Provides Update on Lookman, Bassey, Fredrick’s Fitness Neil the seal has new management plan unveiled Australia v England: second men’s cricket one-day international – live Taxi driver went into blazing, smoke-filled building to save woman and her dog Terrorists killed 835 in October – Report Cat Matlala is a liar – but what parts of his Madlanga evidence should we take seriously? Canadisk soldat død af kvæstelser efter brand på base More Controversies over Lifu’s Judgment as ADC Battles to Remain on the Ballot Police hunt depot worker after colleague gunned down in Penang Micah Reddy | Mashaba, the anti-graft crusader who let the EFF cash in on Joburg
‹ Back to your news

MARKETS

Andrew Forrest-backed biotech in peanut allergy breakthrough

Covered by 1 source First reported

How each outlet tells it

Australian Financial ReviewAU · private

Andrew Forrest-backed biotech in peanut allergy breakthrough

Aravax says clinical trials show there is hope for a more permanent solution to lethal peanut allergies in children.

Read at Australian Financial Review